GlucoTrack Statistics
Share Statistics
GlucoTrack has 14.49M shares outstanding. The number of shares has increased by -73.78% in one year.
| Shares Outstanding | 14.49M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 8.13M |
| Failed to Deliver (FTD) Shares | 12.52K |
| FTD / Avg. Volume | 2.9% |
Short Selling Information
The latest short interest is 37.92K, so 0.66% of the outstanding shares have been sold short.
| Short Interest | 37.92K |
| Short % of Shares Out | 0.66% |
| Short % of Float | 1.22% |
| Short Ratio (days to cover) | 6.03 |
Valuation Ratios
The PE ratio is -0.77 and the forward PE ratio is null.
| PE Ratio | -0.77 |
| Forward PE | null |
| PS Ratio | 0 |
| Forward PS | null |
| PB Ratio | 1.7 |
| P/FCF Ratio | -0.83 |
| PEG Ratio | n/a |
Enterprise Valuation
GlucoTrack Inc. has an Enterprise Value (EV) of -.
| EV / Earnings | null |
| EV / Sales | null |
| EV / EBITDA | null |
| EV / EBIT | null |
| EV / FCF | null |
Financial Position
The company has a current ratio of 3.22, with a Debt / Equity ratio of 0.06.
| Current Ratio | 3.22 |
| Quick Ratio | 3.22 |
| Debt / Equity | 0.06 |
| Total Debt / Capitalization | 5.78 |
| Cash Flow / Debt | -33.46 |
| Interest Coverage | 0 |
Financial Efficiency
Return on equity (ROE) is -2.22% and return on capital (ROIC) is -209.37%.
| Return on Equity (ROE) | -2.22% |
| Return on Assets (ROA) | -1.45% |
| Return on Capital (ROIC) | -209.37% |
| Revenue Per Employee | 0 |
| Profits Per Employee | -1.18M |
| Employee Count | 6 |
| Asset Turnover | 0 |
| Inventory Turnover | 0 |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -78.45% in the last 52 weeks. The beta is 0.16, so GlucoTrack 's price volatility has been higher than the market average.
| Beta | 0.16 |
| 52-Week Price Change | -78.45% |
| 50-Day Moving Average | 1.2 |
| 200-Day Moving Average | 1.93 |
| Relative Strength Index (RSI) | 25.99 |
| Average Volume (20 Days) | 431.61K |
Income Statement
In the last 12 months, GlucoTrack had revenue of $0 and earned -$7.10M in profits. Earnings per share was $-1.92.
| Revenue | 0 |
| Gross Profit | -13.00K |
| Operating Income | -7.10M |
| Net Income | -7.10M |
| EBITDA | -7.09M |
| EBIT | - |
| Earnings Per Share (EPS) | -1.92 |
Balance Sheet
The company has $4.49M in cash and $196.00K in debt, giving a net cash position of $4.30M.
| Cash & Cash Equivalents | 4.49M |
| Total Debt | 196.00K |
| Net Cash | 4.30M |
| Retained Earnings | -109.85M |
| Total Assets | 826.00K |
| Working Capital | -3.97M |
Cash Flow
In the last 12 months, operating cash flow was -$6.56M and capital expenditures $0, giving a free cash flow of -$6.56M.
| Operating Cash Flow | -6.56M |
| Capital Expenditures | 0 |
| Free Cash Flow | -6.56M |
| FCF Per Share | -1.58 |
Margins
Gross margin is 0%, with operating and profit margins of 0% and 0%.
| Gross Margin | 0% |
| Operating Margin | 0% |
| Pretax Margin | 0% |
| Profit Margin | 0% |
| EBITDA Margin | n/a% |
| EBIT Margin | n/a% |
| FCF Margin | n/a% |
Dividends & Yields
GCTK does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -768% |
| FCF Yield | -179.54% |
Analyst Forecast
Currently there are no analyst rating for GCTK.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Stock Splits
The last stock split was on May 20, 2024. It was a backward split with a ratio of 1:5.
| Last Split Date | May 20, 2024 |
| Split Type | backward |
| Split Ratio | 1:5 |
Scores
| Altman Z-Score | -264.92 |
| Piotroski F-Score | 3 |